249 related articles for article (PubMed ID: 19819941)
1. Smad1-Smad5 ovarian conditional knockout mice develop a disease profile similar to the juvenile form of human granulosa cell tumors.
Middlebrook BS; Eldin K; Li X; Shivasankaran S; Pangas SA
Endocrinology; 2009 Dec; 150(12):5208-17. PubMed ID: 19819941
[TBL] [Abstract][Full Text] [Related]
2. Conditional deletion of Smad1 and Smad5 in somatic cells of male and female gonads leads to metastatic tumor development in mice.
Pangas SA; Li X; Umans L; Zwijsen A; Huylebroeck D; Gutierrez C; Wang D; Martin JF; Jamin SP; Behringer RR; Robertson EJ; Matzuk MM
Mol Cell Biol; 2008 Jan; 28(1):248-57. PubMed ID: 17967875
[TBL] [Abstract][Full Text] [Related]
3. Soy promotes juvenile granulosa cell tumor development in mice and in the human granulosa cell tumor-derived COV434 cell line.
Mansouri-Attia N; James R; Ligon A; Li X; Pangas SA
Biol Reprod; 2014 Oct; 91(4):100. PubMed ID: 25165122
[TBL] [Abstract][Full Text] [Related]
4. BMP-specific SMADs function as novel repressors of PDGFA and modulate its expression in ovarian granulosa cells and tumors.
Tripurani SK; Cook RW; Eldin KW; Pangas SA
Oncogene; 2013 Aug; 32(33):3877-85. PubMed ID: 22964636
[TBL] [Abstract][Full Text] [Related]
5. TGFβ signaling promotes juvenile granulosa cell tumorigenesis by suppressing apoptosis.
Mansouri-Attia N; Tripurani SK; Gokul N; Piard H; Anderson ML; Eldin K; Pangas SA
Mol Endocrinol; 2014 Nov; 28(11):1887-98. PubMed ID: 25243859
[TBL] [Abstract][Full Text] [Related]
6. Ovarian granulosa cell tumors express a functional membrane receptor for anti-Müllerian hormone in transgenic mice.
Dutertre M; Gouédard L; Xavier F; Long WQ; di Clemente N; Picard JY; Rey R
Endocrinology; 2001 Sep; 142(9):4040-6. PubMed ID: 11517183
[TBL] [Abstract][Full Text] [Related]
7. Anti-Müllerian hormone inhibits growth of AMH type II receptor-positive human ovarian granulosa cell tumor cells by activating apoptosis.
Anttonen M; Färkkilä A; Tauriala H; Kauppinen M; Maclaughlin DT; Unkila-Kallio L; Bützow R; Heikinheimo M
Lab Invest; 2011 Nov; 91(11):1605-14. PubMed ID: 21808236
[TBL] [Abstract][Full Text] [Related]
8. Misregulated Wnt/beta-catenin signaling leads to ovarian granulosa cell tumor development.
Boerboom D; Paquet M; Hsieh M; Liu J; Jamin SP; Behringer RR; Sirois J; Taketo MM; Richards JS
Cancer Res; 2005 Oct; 65(20):9206-15. PubMed ID: 16230381
[TBL] [Abstract][Full Text] [Related]
9. Dominant-stable beta-catenin expression causes cell fate alterations and Wnt signaling antagonist expression in a murine granulosa cell tumor model.
Boerboom D; White LD; Dalle S; Courty J; Richards JS
Cancer Res; 2006 Feb; 66(4):1964-73. PubMed ID: 16488995
[TBL] [Abstract][Full Text] [Related]
10. Constitutively active transforming growth factor β receptor 1 in the mouse ovary promotes tumorigenesis.
Gao Y; Vincent DF; Davis AJ; Sansom OJ; Bartholin L; Li Q
Oncotarget; 2016 Jul; 7(27):40904-40918. PubMed ID: 27344183
[TBL] [Abstract][Full Text] [Related]
11. SMAD3 Activation: A Converging Point of Dysregulated TGF-Beta Superfamily Signaling and Genetic Aberrations in Granulosa Cell Tumor Development?
Fang X; Gao Y; Li Q
Biol Reprod; 2016 Nov; 95(5):105. PubMed ID: 27683263
[TBL] [Abstract][Full Text] [Related]
12. Expression of anti-Müllerian hormone (AMH) in equine granulosa-cell tumors and in normal equine ovaries.
Ball BA; Conley AJ; MacLaughlin DT; Grundy SA; Sabeur K; Liu IK
Theriogenology; 2008 Oct; 70(6):968-77. PubMed ID: 18599114
[TBL] [Abstract][Full Text] [Related]
13. Functional redundancy of TGF-beta family type I receptors and receptor-Smads in mediating anti-Mullerian hormone-induced Mullerian duct regression in the mouse.
Orvis GD; Jamin SP; Kwan KM; Mishina Y; Kaartinen VM; Huang S; Roberts AB; Umans L; Huylebroeck D; Zwijsen A; Wang D; Martin JF; Behringer RR
Biol Reprod; 2008 Jun; 78(6):994-1001. PubMed ID: 18322278
[TBL] [Abstract][Full Text] [Related]
14. Smad1/5 is required for erythropoietin-mediated suppression of hepcidin in mice.
Wang CY; Core AB; Canali S; Zumbrennen-Bullough KB; Ozer S; Umans L; Zwijsen A; Babitt JL
Blood; 2017 Jul; 130(1):73-83. PubMed ID: 28438754
[TBL] [Abstract][Full Text] [Related]
15. Either Kras activation or Pten loss similarly enhance the dominant-stable CTNNB1-induced genetic program to promote granulosa cell tumor development in the ovary and testis.
Richards JS; Fan HY; Liu Z; Tsoi M; Laguë MN; Boyer A; Boerboom D
Oncogene; 2012 Mar; 31(12):1504-20. PubMed ID: 21860425
[TBL] [Abstract][Full Text] [Related]
16. Immunohistochemical phenotype of ovarian granulosa cell tumors: absence of epithelial membrane antigen has diagnostic value.
Costa MJ; DeRose PB; Roth LM; Brescia RJ; Zaloudek CJ; Cohen C
Hum Pathol; 1994 Jan; 25(1):60-6. PubMed ID: 8314261
[TBL] [Abstract][Full Text] [Related]
17. Aberrant granulosa cell-fate related to inactivated p53/Rb signaling contributes to granulosa cell tumors and to FOXL2 downregulation in the mouse ovary.
Cluzet V; Devillers MM; Petit F; Chauvin S; François CM; Giton F; Genestie C; di Clemente N; Cohen-Tannoudji J; Guigon CJ
Oncogene; 2020 Feb; 39(9):1875-1890. PubMed ID: 31745296
[TBL] [Abstract][Full Text] [Related]
18. Endogenous c-Jun N-terminal kinase (JNK) activity marks the boundary between normal and malignant granulosa cells.
Bildik G; Akin N; Senbabaoglu F; Esmalian Y; Sahin GN; Urman D; Karahuseyinoglu S; Ince U; Palaoglu E; Taskiran C; Arvas M; Guzel Y; Yakin K; Oktem O
Cell Death Dis; 2018 Apr; 9(4):421. PubMed ID: 29549247
[TBL] [Abstract][Full Text] [Related]
19. Common partner Smad-independent canonical bone morphogenetic protein signaling in the specification process of the anterior rhombic lip during cerebellum development.
Tong KK; Kwan KM
Mol Cell Biol; 2013 May; 33(10):1925-37. PubMed ID: 23459943
[TBL] [Abstract][Full Text] [Related]
20. High GATA-4 expression associates with aggressive behavior, whereas low anti-Müllerian hormone expression associates with growth potential of ovarian granulosa cell tumors.
Anttonen M; Unkila-Kallio L; Leminen A; Butzow R; Heikinheimo M
J Clin Endocrinol Metab; 2005 Dec; 90(12):6529-35. PubMed ID: 16159935
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
